| Ytd | 662.97% | |
| 1y | 717.29% |
| Open | 199.10 | Prev Close | 197.00 | Low | 197.17 | High | 225.00 | Mkt Cap | 89.83B |
| Vol | 28.95M | Avg Vol | 17.95M | EPS | -9.11 | P/E | N/A | Forward P/E | -50.70 |
| Beta | 1.09 | Short Ratio | 0.99 | Inst. Own | 80.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 134.92 | 200-d Avg | 71.68 | 1yr Est | 122.67 |
Investors turned away from Moderna in recent years as its blockbuster coronavirus vaccine saw declin
The market made a modest gain - but most stocks got left behind.
The National Institutes of Health (NIH) is reportedly planning to launch a cancer vaccine developmen
Moderna shares are rising Friday to a fresh 52-week high. The stock enters the Nasdaq-100 Index. Her
A new NIH-backed initiative to speed up personalized cancer vaccine development sent stocks like MRN
Vaccine and biotechnology names are leading a sharp sector rally, and a small protein-vaccine develo
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
The Nasdaq 100 recovers from Thursday's OpenAI-driven selloff while T-Mobile sinks 12% on SpaceX
Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock trades at $207.80, up 5%, after its addition to
Moderna MRNA shares jumped more than 9% in early trading Friday, reaching a fresh 52-week high as th
U.S. stocks rose Friday; Humana jumped 12.3% after improved 2027 Medicare Advantage ratings and reaf
Arbutus Biopharma is rated Buy, leveraging a $179.1M Moderna settlement and a 46M share buyback to e
MRNA's Nasdaq-100 entry follows a 566% stock surge and stronger cancer therapy prospects, potentiall
Three stocks left the S&P 500's 2025 return in the dust, but gains that large raise one uncomfortabl
Axsome Therapeutics is seeing massive revenue growth as it expands its footprint in the central nerv
The healthcare sector stood out as one of the few bright spots in Wednesday's trading.
During the quarter, we closed our long positions in MTY Food Group, uniQure, ClearPoint Neuro, and S
Tempus Inc. (NASDAQ:TEM) on Wednesday expanded its multi-year collaboration for intismeran autogene
Tempus AI expands its collaboration with Moderna and Merck to support sample collection and NGS serv
Morgan Stanley analyst Terence Flynn maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and rais
CHICAGO--(BUSINESS WIRE)--Tempus (NASDAQ: TEM) today announced an expanded, multi-year collaboration
These stocks have all soared more than 350% this year.
Few large biotech stocks have rewarded patience like Moderna (NASDAQ:MRNA | MRNA Price Prediction),
All three major indexes are higher today, with the Nasdaq and S&P 500 scoring new record highs as bo
Moderna, Inc. (NASDAQ: MRNA - Get Free Report) reached a new 52-week high during trading on Tuesday.
A plague headline out of Siberia lifted vaccine stocks, and the agencies closest to the case have si
Vaccine stocks are trending on Tuesday. Shares of Moderna Inc. (NASDAQ:MRNA), Vaxcyte Inc. (NASDA
Unconfirmed plague fears sent Novavax up 24% in a potential short squeeze, lifting vaccine stocks de
Sanofi is carrying the Nuvaxovid COVID-19 shot into the fall vaccination season, and buyers are rewa
Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are trading as though the company's messenge
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Moderna Inc (NASDAQ:MRNA) shares are trending Thursday as the stock continues working through volati
A key trading signal flashed for Moderna shares at a price of $186.46, after which MRNA rose over 3%
Moderna stock dips as Juan Andres returns as COO, Jerh Collins retires, and the company expands its
Nasdaq 100 gains as softer PCE inflation cools Fed rate-hike bets, with oil above $91 and Micron ear
Analysts downgraded SoundThinking, Moderna, Accelerant, Mobileye and Dow, revising their ratings and
Analysts revised targets and ratings for KMX, ARX, JKHY, MRNA, GO, HNGE, AYTU and MSFT, with mixed u
Concentrix plunged 10.6% premarket after weak guidance, despite an earnings beat; several other stoc
Citigroup analyst Geoff Meacham downgrades Moderna (NASDAQ:MRNA) from Neutral to Sell and raises
Moderna shares are climbing again Tuesday, touching a new 52-week high of $208.90 on continued momen
AMD crossed $1 trillion and Meta's Muse rattled subscription stocks. Meanwhile, Treasury yields
Moderna Inc. (NASDAQ: MRNA) shares are trading higher Friday, hitting a fresh 52-week high on antici
Moderna shares rose 0.09% after hours Thursday as investors eyed upcoming oncology data at a major E
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
U.S. stocks fell as Nasdaq dropped 100+ points, while TriSalus surged 5.8% on FDA clearance; Securit
Thermo Fisher, Moderna and Agilent show overbought RSI readings above 70, warning momentum-focused i
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Moderna shares are surging Monday. The company announced three intismeran autogene abstracts were ac
Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on intismeran autogene, an investig
U.S. stocks rose Monday, with Nasdaq up 1%. Critical Metals jumped 38% on Greenland deal news as tec